Fig. 6.
In vitro cellular uptake study of the micelles in NE cancer cells. Flow cytometry analysis of (A) BON cells, and (B) MZ–CRC–1 cells. CLSM images of (C) BON cells, and (D) MZ–CRC–1 cells. Cells were treated with pure medium (control) and non-targeted or KE108-conjugated (targeted) micelles (100 μg/ml) for 2 h at 37 °C. The KE108 peptide significantly enhanced the cellular uptake of micelles in both NE cancer cell lines.
